Biotech Acquisition (OTCMKTS:BIOTU – Get Free Report)’s share price dropped 7.7% during mid-day trading on Friday. The stock traded as low as $10.14 and last traded at $10.14. Approximately 1,300 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 4,444 shares. The stock had previously closed at $10.98.
Biotech Acquisition Stock Performance
The business has a 50-day moving average price of $10.14 and a 200-day moving average price of $10.14.
Biotech Acquisition Company Profile
Biotech Acquisition is a special purpose acquisition company (SPAC) established to identify and complete a business combination with a company in the biotechnology, life sciences, healthcare, or a related industry. Rather than operating a conventional commercial business, the company’s primary activities involve evaluating potential acquisition targets, negotiating a transaction, and seeking shareholder approval for a merger, acquisition, or similar combination. Its publicly traded units are associated with securities intended to provide investors with exposure to the company’s eventual business combination.
Read More
- Five stocks we like better than Biotech Acquisition
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
